What is Sarepta Therapeutics, Inc.'s noncash interest expense?

Sarepta Therapeutics, Inc. (SRPT) reported noncash interest expense of $9.61M in Q1 2026.

How has Sarepta Therapeutics, Inc.'s noncash interest expense changed year-over-year?

Sarepta Therapeutics, Inc.'s noncash interest expense increased by 666.5% year-over-year, from $1.25M to $9.61M.

What does noncash interest expense mean?

Includes non-cash interest charges such as the amortization of debt discounts, premiums, or issuance costs. It provides insight into the true cost of borrowing beyond the cash interest payments made to creditors.

Sarepta Therapeutics, Inc. SRPT Noncash Interest Expense

Noncash Interest Expense at other companies

NovantaNOVT

$368K+26.7%

Laureate Education, Inc.LAUR

$593K+56.1%

Rhythm Pharmaceuticals, Inc.RYTM

$4.58M-15.4%

Galaxy Digital Inc. Class A Common StockGLXY

$17.58M+24.9%

Disc MedicineIRON

$206K-0.5%

D-Wave QuantumQBTS

$234K+24.5%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.82B-63.1%

Enterprise value$1.56B-67.2%

P/S0.8×—

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept srpt:NoncashInterestExpense.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s noncash interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s noncash interest expense?: Sarepta Therapeutics, Inc. (SRPT) reported noncash interest expense of $9.61M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s noncash interest expense changed year-over-year?: Sarepta Therapeutics, Inc.'s noncash interest expense increased by 666.5% year-over-year, from $1.25M to $9.61M.
What does noncash interest expense mean?: Includes non-cash interest charges such as the amortization of debt discounts, premiums, or issuance costs. It provides insight into the true cost of borrowing beyond the cash interest payments made to creditors.